International Agencies

This document provides general guidance and examples on implementing contact investigations in low- and middle-income settings. The World Health Organization (WHO) policy document "Recommendations for Inves­tigating Contacts of Persons with Infectious Tuberculosis in Low- and Middle-Income Countries", published in late 2012, presents definitions and recommendations for what should be done for contact investigation; this doc­ument presents suggestions and examples of how the recommendations can be put into operation.

The objectives of this document are to describe the best practices in engaging different health providers and partners in the management of drug-resistant TB patients and to describe the necessary components in planning and implementing a public-private mix for the management of drug-resistant TB.

This document outlines the United States Government's global TB strategy.

This document presents guidance on the design and implementation of surveys and surveillance systems to measure the burden and trends of drug-resistant tuberculosis.

This facilitators’ guide for training community health workers and community volunteers is intended for training in tuberculosis (TB) and integration of TB prevention and care services into community-based activities.

This is the 20th global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 200 countries and territories that account for over 99% of the world’s TB cases.

This document highlights strategic directions to integrate digital health into TB prevention and care activities in support of WHO’s End TB Strategy.

This document provides practical guidance on translating the World Health Organization's principles and recommendations into a national or local screening strategy.

The primary purposes of this framework are to: 1) promote, enhance, and intensify TB research and innovation at the country level, and 2) promote, enhance, and catalyze TB research at the global level through advocacy, innovation, discussion of global priorities, and the development of networks for research and capacity building.

This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.